Home Situations IONS — Gap to peers
Situation · 2026-06-12

IONS — Gap to peers

Premium Rides on Pipeline Momentum, Not Margins

Updated 2026-06-04 · Ref: Biotechnology
Key metrics — 2026-06-04
Peer score
40
Quality pct
23
Valuation pct
30
52w drawdown
-13.1%
21d vs sector
-2.1%
Peer group
Biotechnology
Situation summary

The premium on IONS is all about pipeline speed, not margin strength. Revenue is up 87% year-on-year, but operating margin sits at -24%. The market jumps on every pipeline update. One bad launch and the stock could drop hard.

Published by AssetNext · 2026-06-09

All companies with this signal today

View full list: Gap to peers →

Related pages for IONS
Full peer analysis for Ionis Pharmaceuticals, Inc. →Similar companies to IONSIONS peersAll IONS comparisonsRussell 1000 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-06-04 Gap to peers 40 -13.1% -2.1%
2026-05-26 Gap to peers 40 -12.1% +4.1%
2026-05-22 Gap to peers 40 -12.6% +0.9%
2026-05-19 Gap to peers 40 -14.6% -4.4%

See IONS's full peer analysis

Break down IONS's structural position across all peer dimensions with the interactive app.

Open IONS in AssetNext →